M. Scully Et Al. , "Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura," NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.4, pp.335-346, 2019
Scully, M. Et Al. 2019. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.4 , 335-346.
Scully, M., Cataland, S., Peyvandi, F., Coppo, P., Knöl, P., Kremer Hovinga, J., ... Metjian, A.(2019). Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.4, 335-346.
Scully, M. Et Al. "Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura," NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.4, 335-346, 2019
Scully, M. Et Al. "Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura." NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.4, pp.335-346, 2019
Scully, M. Et Al. (2019) . "Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura." NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.4, pp.335-346.
@article{article, author={M. Scully Et Al. }, title={Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2019, pages={335-346} }